Tradestie Institutional Equity Comparison Engine

NPCE vs PMI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PMI Overall Edge

PMI Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Picard Medical, Inc. (PMI) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while NPCE counters with relative strength in Valuation. Fundamentally, NPCE trades at 90.9x Forward P/E with -9.6% operating margin (-1.1% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, NPCE sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner NPCE
NPCE 90.9x vs PMI N/M Fwd P/E
Growth & Margin Winner PMI
Op Margin -9.6% vs -248.1% ยท YoY -1.1% vs +38.6%
Momentum & Technical Winner PMI
1Y -37.5% vs +107.2% ยท 52W Pos 19% vs 34%
Options & Structure Winner PMI
BREAKDOWN (10th %ile IV) vs UNCLASSIFIED (N/A IV)
NPCE NASDAQ
Neuropace, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$8.14
-0.97% 1D
Market Cap $283.2M
1M Return -37.62%
1Y Return -37.48%
Forward P/E 90.9x
Unified AI Score
48.8 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 71.0 Mom 48.9
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NPCE -37.48% PMI +107.24% Spread: +185.51 pp (PMI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NPCE Revenue PMI Revenue NPCE Op. Margin PMI Op. Margin Margin Edge
FY2020 $40M N/A -31.7% N/A NPCE
FY2021 $50M N/A -52.5% N/A NPCE
FY2022 $50M N/A -89.6% N/A NPCE
FY2023 $70M N/A -41.5% N/A NPCE
FY2024 $80M $0M -27.1% -312.3% NPCE
FY2025 $100M $0M -16.3% -268.4% NPCE

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NPCE (4) vs PMI (6)
Institutional Metric NPCE PMI Criterion Row Winner
Market Capitalization Scale $283.2M $17.1M Larger Scale NPCE
Trailing P/E Ratio Valuation 90.9x 2.9x Lower Multiple PMI
Forward P/E Ratio Valuation 90.9x N/M Lower Multiple NPCE
Revenue Growth (YoY) Growth -1.1% +38.6% Higher Growth PMI
Operating Margin (TTM) Profitability -9.6% -248.1% Higher Margin NPCE
Net Profit Margin Profitability -17.7% 0.0% Higher Margin PMI
Return on Equity (ROE) Capital Efficiency -97.0% 0.0% Higher ROE PMI
52-Week Range Position Momentum 19% ($5โ€“$20) 34% ($0โ€“$18) Stronger Trend PMI
Beta / 30D Volatility Risk Regime 1.22ฮฒ ยท 136% Vol 54.06ฮฒ ยท 134% Vol Lower Realized Risk PMI
Unified Institutional Score Composite Signal 48.8 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite NPCE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NPCE vs PMI Buy Guide
NPCE BREAKDOWN
136d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live NPCE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NPCE nor PMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.